roduction
rently elderly people have a higher incidence of the four major tumor types than any other age group, yet there is a fundamental lack of knowledge regarding the treatment of elderly cancer patients, resulting in their under-treatment. This means that elderly cancer patients form an untapped market opportunity for healthcare providers and pharmaceutical manufacturers.
Scope
* An overview of the epidemiology of four main tumor types amongst the elderly.
* Discussions concerning the problems associated with clinical trials and the treatment of elderly cancer patients.
* An overview of the different methods of treatment used in elderly patients.
* Case studies of breast and lung cancer treatment in the elderly.
Report Highlights
There is a fundamental lack of knowledge regarding the treatment of elderly cancer patients, resulting in under-treatment. Datamonitor recommends that pharmaceutical companies research treatment strategies aimed specifically at elderly patients to encourage higher prescribing levels.